Canada Goose (NYSE:GOOS) Trading Up 10.4% - Still a Buy?

Shares of Canada Goose Holdings Inc. (NYSE:GOOS - Get Free Report) shot up 10.4% during mid-day trading on Monday . The stock traded as high as $11.59 and last traded at $11.50. 752,483 shares were traded during trading, a decline of 20% from the average session volume of 937,134 shares. The stock had previously closed at $10.41.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on GOOS. The Goldman Sachs Group cut their price objective on shares of Canada Goose from $9.00 to $8.00 and set a "sell" rating for the company in a research note on Tuesday, December 10th. Barclays lowered their price target on Canada Goose from $11.00 to $10.00 and set an "equal weight" rating for the company in a research report on Monday, February 10th. Finally, Evercore ISI reduced their price target on shares of Canada Goose from $13.00 to $10.00 and set an "in-line" rating for the company in a research report on Monday, February 10th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $10.60.

Canada Goose Stock Performance

The company has a debt-to-equity ratio of 0.81, a current ratio of 2.01 and a quick ratio of 1.14. The company has a market cap of $1.02 billion, a PE ratio of 20.24, a PEG ratio of 1.00 and a beta of 1.31. The business has a 50-day moving average of $10.32 and a 200 day moving average of $10.47.

Remove Ads

Canada Goose (NYSE:GOOS - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.10 EPS for the quarter, meeting analysts' consensus estimates of $1.10. Canada Goose had a net margin of 5.47% and a return on equity of 22.49%. Equities research analysts anticipate that Canada Goose Holdings Inc. will post 0.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Canada Goose

Institutional investors and hedge funds have recently bought and sold shares of the stock. The Manufacturers Life Insurance Company increased its position in Canada Goose by 42.9% in the third quarter. The Manufacturers Life Insurance Company now owns 5,554,279 shares of the company's stock worth $69,595,000 after buying an additional 1,667,750 shares in the last quarter. Patient Capital Management LLC increased its holdings in Canada Goose by 3.4% in the 4th quarter. Patient Capital Management LLC now owns 3,854,520 shares of the company's stock worth $38,661,000 after acquiring an additional 128,133 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Canada Goose in the 4th quarter worth approximately $12,251,000. Scheer Rowlett & Associates Investment Management Ltd. raised its stake in Canada Goose by 1.2% during the 4th quarter. Scheer Rowlett & Associates Investment Management Ltd. now owns 1,218,326 shares of the company's stock worth $12,223,000 after acquiring an additional 14,341 shares during the period. Finally, Pinnacle Associates Ltd. lifted its holdings in Canada Goose by 0.6% during the third quarter. Pinnacle Associates Ltd. now owns 602,341 shares of the company's stock valued at $7,138,000 after purchasing an additional 3,338 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Canada Goose

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.